All In Biotech

Drug Trial Radar · NCT02140255

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

1,120

Planned (sponsor's estimate)

Start

Jan 23, 2015

Primary completion

Jan 31, 2028

Study completion Dec 31, 2031

Sponsor

Sponsor type
NIH
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH)
First posted
May 16, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, up to 48 hours
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among infants living with HIV.

Conditions

  • HIV Infection

Interventions

  • Nucleoside Reverse Transcriptase Inhibitors (NRTIs)Drug

    Chosen by the site investigator and dosed according to World Health Organization (WHO) or individual country or local standard guidelines.

  • Nevirapine (NVP)Drug

    Administered orally. Dosed according to study step/participant's age/participant's weight.

  • Lopinavir/Ritonavir (LPV/r)Drug

    Administered orally. Dosed according to study step and participant's age.

  • Raltegravir (RAL)Drug

    Administered orally. Dosed according to study step and participant's age.

  • VRC01Drug

    40 mg/kg administered subcutaneously.

  • Dolutegravir (DTG)Drug

    Dosed according to study step/participant's age/participant's weight

  • VRC07-523LSDrug

    40 mg/kg administered subcutaneously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants who achieve HIV remissionTime frame: Measured through Week 48

Locations

47 sites in 13 countries. Site status is shown where the registry gives one.

  • 4601, University of California, San Diego Clinical Research Site

    La Jolla, California · Completed

  • 5048, University of Southern California Clinical Research Site

    Los Angeles, California · Recruiting

  • 5112, David Geffen School of Medicine at UCLA Clinical Research Site

    Los Angeles, California · Recruiting

  • 5052, University of Colorado, Denver Clinical Research Site

    Aurora, Colorado · Recruiting

  • 5055, South Florida CDTC Fort Lauderdale Clinical Research Site

    Fort Lauderdale, Florida · Completed

  • 5051, University of Florida Center for HIV/AIDS Research, Education and Service (UF CARES) Clinical Research Site

    Jacksonville, Florida · Recruiting

  • 5127, Pediatric Perinatal HIV Clinical Research Site

    Miami, Florida · Withdrawn

  • Emory University School of Medicine NICHD CRS

    Atlanta, Georgia · Withdrawn

  • 32515, Rush Univ./Cook County Hosp. Chicago CRS

    Chicago, Illinois · Recruiting

  • 5083, Rush University Cook County Hospital Clinical Research Site

    Chicago, Illinois · Withdrawn

  • 4001, Lurie Children's Hospital of Chicago Clinical Research Site

    Chicago, Illinois · Recruiting

  • 5092, Johns Hopkins Clinical Research Site

    Baltimore, Maryland · Recruiting

  • Boston Medical Center Ped. HIV Program NICHD CRS

    Boston, Massachusetts · Withdrawn

  • 5040, SUNY Stony Brook Clinical Research Site

    Stony Brook, New York · Withdrawn

  • 5114, Bronx Lebanon Hospital Center Clinical Research Site

    The Bronx, New York · Recruiting

  • 5013, Jacobi Medical Center Clinical Research Site

    The Bronx, New York · Recruiting

  • Philadelphia IMPAACT Unit CRS

    Philadelphia, Pennsylvania · Withdrawn

  • 6501, St Jude Children's Research Hospital Clinical Research Site

    Memphis, Tennessee · Recruiting

  • 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site

    Houston, Texas · Recruiting

  • Seattle Children's Research Institute CRS

    Seattle, Washington · Withdrawn

  • Univ. of Washington NICHD CRS

    Seattle, Washington · Withdrawn

  • Hosp. General de Agudos Buenos Aires Argentina NICHD CRS

    Buenos Aires, Argentina · Withdrawn

  • 5073, School of Medicine Federal University Minas Gerais Clinical Research Site

    Minas Gerais, Brazil · Recruiting

  • 5072, Hospital Federal dos Servidores do Estado Clinical Research Site

    Rio de Janeiro, Brazil · Completed

  • 5071, Instituto de Puericultura e Pediatria Martagao Gesteira Clinical Research Site

    Rio de Janeiro, Brazil · Recruiting

  • 5097, Hospital Geral de Nova Igaucu Clinical Research Site

    Rio de Janeiro, Brazil · Completed

  • 5074, University of Sao Paulo Clinical Research Site

    São Paulo, Brazil · Completed

  • Hospital Nossa Senhora da Conceicao NICHD CRS

    Porto Alegre, Rio Greande Do Sul, Brazil · Completed

  • 30022, Les Centres GHESKIO Clinical Research Site

    Port-au-Prince, Haiti · Recruiting

  • 5121, Kenya Medical Research Institute/Walter Reed Project Clinical Research Center Kericho Clinical Research Site

    Kericho, Kenya · Recruiting

  • 30301, Blantyre Clinical Research Site

    Blantyre, Malawi · Recruiting

  • 12001, Malawi Clinical Research Site

    Lilongwe, Central Region, Malawi · Recruiting

  • 32513, IMPAACT/ Gamma Project/ UPR Pediatric HIV/AIDS Research Network CRS

    San Juan, PR, Puerto Rico · Withdrawn

  • San Juan City Hosp. PR NICHD CRS

    San Juan, Puerto Rico, Puerto Rico · Withdrawn

  • Soweto IMPAACT CRS

    Johannesburg, Gauteng, South Africa · Completed

  • Wits RHI Shandukani Research Centre CRS

    Johannesburg, Gauteng, South Africa · Completed

  • 30300, Umlazi Clinical Research Site

    Durban, KwaZulu-Natal, South Africa · Recruiting

  • 8950, FAMCRU Clinical Research Site

    Tygerberg, Western Cape, South Africa · Completed

  • 5118, Kilimanjaro Christian Medical Centre Clinical Research Site

    Moshi, Tanzania · Recruiting

  • 5116, Chiangrai Prachanukroh Hospital Clinical Research Site

    Chiang Mai, Thailand · Recruiting

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.